Menstrual characteristics in Korean women with endometriosis: a pilot study

Similar documents
The serum estradiol/oocyte ratio in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins

Hana Park, Chung-Hoon Kim, Eun-Young Kim, Jei-Won Moon, Sung-Hoon Kim, Hee-Dong Chae, Byung-Moon Kang

Preoperative Serum Anti-Mullerian Hormone Level in Women with Ovarian Endometrioma and Mature Cystic Teratoma

Original Article. Introduction


Risk Profiles for Endometriosis in Japanese Women: Results From a Repeated Survey of Self-Reports

Dienogest compared with gonadotropin-releasing hormone agonist after conservative surgery for endometriosis

Prognosticating ovarian reserve by the new ovarian response prediction index

Clinica Ostetrica e Ginecologica I, Istituto Luigi Mangiagalli, University of Milano, Milan, Italy

REPRODUCTIVE ENDOCRINOLOGY

TheFormationofaScoringSystemtoDiagnoseEndometriosis. The Formation of a Scoring System to Diagnose Endometriosis

PREGNANCY AND RECURRENCE RATES IN INFERTILE PATIENTS OPERATED FOR OVARIAN ENDOMETRIOSIS

Ovarian Response to Gonadotrophin Stimulation in Patients with Previous Endometriotic Cystectomy

1. Attia AM et al. Role of the levonorgestrel intrauterine system in effective contraception. Patient Prefer Adherence 2013; 7:

Role of diagnostic hysteroscopy in evaluation of abnormal uterine bleeding and its histopathological correlation

Demographic, biological and dietary characteristics associated with endometriosis in a group of Sri Lankan women

Neutrophil-to-lymphocyte ratio as an adjunct to CA-125 for the diagnosis of endometriosis

Chapter 100 Gynecologic Disorders

(BMI)=18.0~24.9 kg/m 2 ;

Medical treatment for uterine fibroids

Natural hair color and the incidence of endometriosis

Managing infertility when adenomyosis and endometriosis co-exist

A multi-centre, multinational, cross-sectional, incident case control study on Factors associated with the development of

Embryonic development in human oocytes fertilized by split insemination

ISUOG Basic Training Typical Ultrasound Appearances of Common Pathologies in the Adnexae

Does Ovarian Cysts affect your Fertility?

A Prospective Observational Study to Evaluate the Efficacy and Safety Profiles of Leuprorelin 3 Month Depot for the Treatment of Pelvic Endometriosis

Structured teaching programme on knowledge about polycystic ovarian syndrome among adolescent girls

COLLEGE OF OBSTETRICIANS AND GYNAECOLOGISTS, SINGAPORE 2006

A study of benign adnexal masses

Clinical outcomes of frozen embryo transfer cycles after freeze-all policy to prevent ovarian hyperstimulation syndrome

Surgical treatment of endometriosis: location and patterns of disease at reoperation

The Role of Ormeloxifene in the Management of Dysfunctional Uterine Bleeding: A Prospective Clinical Study

Index. Note: Page numbers of article titles are in boldface type.

Thyroid Dysfunction Associated with Administration of the Long-Acting Gonadotropin-Releasing Hormone Agonist

Chapter 3. Renato Seracchioli Mohamed Mabrouk Clarissa Frascà Linda Manuzzi Luca Savelli Stefano Venturoli Fertil Steril Jul; 94(2):

REPRODUCTIVE ENDOCRINOLOGY

Int J Clin Exp Med 2016;9(10): /ISSN: /IJCEM

The effect of tamoxifen therapy on the endometrium and ovarian cyst formation in patients with breast cancer

The many faces of Endometriosis

Pre and post surgical medical therapy. Mauro Busacca M.D. Dept of Obstetrics and Gynecology University of Milan- Italy

The Correlation between Serum and Peritoneal Fluid CA125 Level in Women with Pelvic Endometriosis

Selected risk factors of infertility in women: case control study

Evaluation of Risk Factors Associated with Endometriosis in Infertile Women

PALM-COEIN: Your AUB Counseling Guide

J of Evolution of Med and Dent Sci/ eissn , pissn / Vol. 4/ Issue 73/ Sept 10, 2015 Page 12639

Factors influencing serum progesterone level on triggering day in stimulated in vitro fertilization cycles

Uterine fibroid shrinkage after short-term use of selective progesterone receptor modulator or gonadotropin-releasing hormone agonist

Prevalence of Sarcopenia Adjusted Body Mass Index in the Korean Woman Based on the Korean National Health and Nutritional Examination Surveys

Significance of Ovarian Endometriosis on the Prognosis of Ovarian Clear Cell Carcinoma

Palm Beach Obstetrics & Gynecology, PA

Clinical predictive factors for endometriosis in a Portuguese infertile population

Freedom of Information

Uterine-Sparing Treatment Options for Symptomatic Uterine Fibroids

Stimulated intrauterine insemination in women with unilateral tubal occlusion

Contraception and gynecological pathologies

Renato Seracchioli, M.D., Mohamed Mabrouk, M.D., Clarissa Frasca, M.D., Linda Manuzzi, M.D., Luca Savelli, M.D., and Stefano Venturoli, M.D.

Impact of Ovarian Endometrioma Per Se and Surgery on Ovarian Reserve and Pregnancy Rate in in Vitro Fertilization Cycles

CY Tse, AMK Chow, SCS Chan. Introduction

5 Mousa Al-Abbadi. Ola Al-juneidi & Obada Zalat. Ahmad Al-Tarefe

Endometriosis and Infertility - FAQs

Surgical Interruption of Pelvic Nerve Pathways for Primary and Secondary Dysmenorrhea

Comparison of anti-mullerian hormone level in nonendometriotic benign ovarian cyst before and after laparoscopic cystectomy

FDG-PET value in deep endometriosis

Clinical Study Laparoscopic Surgery in Elderly Patients Aged 65 Years and Older with Gynecologic Disease

1. Attia AM et al. Role of the levonorgestrel intrauterine system in effective contraception. Patient Prefer Adherence 2013; 7:

Supernumerary ovary on recto-sigmoid colon with associated endometriosis

My Patient Has Pelvic Pain. David A. Kenny DO

Prevalence of dysmenorrhea in young women (16 25 years): A cross-sectional study

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Downloaded from:

2/24/19. Myometrial evaluation. Size Echotexture. Homogeneous Heterogeneous. Adenomyosis Fibroids. Adenomyosis. MUSA guidelines

Kissing ovaries : a sonographic sign of moderate to severe endometriosis

A prospective study of dietary fat consumption and endometriosis risk

INFERTILITY CAUSES. Basic evaluation of the female

RESEARCH COMMUNICATION

Cancer after ART. A Dutch nationwide historic cohort of women who received IVF treatment in the

Case Report. Introduction. Seul Ki Kim 1,2*, Myo Sun Kim 1*, Hoon Kim 2, Sun Mie Kim 2,3, Jung Ryeol Lee 1,2, Chang Suk Suh 1,2, Seok Hyun Kim 2

DR. FAREEHA NAEEM, MBBS NISHTAR HOSPITAL, MULTAN DR. MAMOONA TARIQ, MBBS NISHTAR HOSPITAL, MULTAN DR. SEHRISH RASHEED, MBBS NISHTAR HOSPITAL, MULTAN

Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial

The effect of luteal phase progesterone supplementation on natural frozen-thawed embryo transfer cycles

Gonadotrophin-releasing hormone agonist combined with high-intensity focused ultrasound ablation for adenomyosis: a clinical study

Surgical Interruption of Pelvic Nerve Pathways for Primary and Secondary Dysmenorrhea. Original Policy Date

Comparison between hysterosalpingography and laparoscopic chromopertubation for the assessment of tubal patency in infertile women

Efficacy of Random-start Controlled Ovarian Stimulation in Cancer Patients

Open Access Original Article

Age specific serum anti-müllerian hormone levels in 1,298 Korean women with regular menstruation

Effectiveness of Dienogest for Treatment of Recurrent Endometriosis: Multicenter Data

Gonadotropin releasing hormone antagonist administration for treatment of early type severe ovarian hyperstimulation syndrome: a case series

Cancer Risks of Ovulation Induction

Nomogram predicting risk of lymphocele in gynecologic cancer patients undergoing pelvic lymph node dissection

OUTCOMES OF ROBOTIC, LAPAROSCOPIC AND OPEN ABDOMINAL HYSTERECTOMY FOR BENING CONDITIONS IN OBESE PATIENTS

Tubal ligation, hysterectomy, unilateral oophorectomy, and risk of ovarian cancer in the Nurses Health Studies

Endometriosis. *Chocolate cyst in the ovary

Disordered eating and distress in the in vitro fertilization population: preliminary results of a pilot study

Moneli Golara Consultant Obstetrician and Gynaecologist Barnet Hospital Royal Free NHS Trust

Work Loss Associated With Increased Menstrual Loss in the United States

The diagnosis of endometriomas using colour Doppler energy imaging

International Journal of Scientific Research and Reviews

A Practical Approach to Adnexal Masses

Transcription:

Original Article Obstet Gynecol Sci 2018;61(1):142-146 https://doi.org/10.5468/ogs.2018.61.1.142 pissn 2287-8572 eissn 2287-8580 Menstrual characteristics in Korean women with endometriosis: a pilot study Ji Yeon Han 1,2, Eun Ji Lee 1, Byung Chul Jee 2,3, Seok Hyun Kim 1,2 Department of Obstetrics and Gynecology, 1 Seoul National University Hospital, 2 Seoul National University College of Medicine, Seoul, 3 Seoul National University Bundang Hospital, Seongnam, Korea Objective This study aimed to determine whether the menstrual characteristics are different in Korean women with or without ovarian endometrioma. Methods We selected 95 premenopausal women aged below 39 years who underwent laparoscopic surgery for ovarian endometrioma (n=46) or other benign ovarian tumors (n=49) between April 2016 and February 2017. We excluded those with uterine diseases that could potentially affect the menstrual characteristics and those on anticoagulants or hormonal medication. At admission, menstrual characteristics such as cycle length, cycle regularity, and menstrual duration, were collected. In addition, amount of menstrual bleeding and severity of dysmenorrhea were recorded using a pictorial blood loss assessment chart (PBAC) and visual analogue scale, respectively. Results Age and parity were similar in both women with ovarian endometrioma and women with other benign ovarian tumors. Body mass index (BMI) was significantly lower (median, 20.9 vs. 22.1 kg/m 2 ; P=0.031) in women with ovarian endometrioma. The amount of menstrual bleeding (median PBAC score, 183 vs. 165), menstrual duration (median, 6 vs. 6 days), and cycle length in women with regular cycle (median, 29.0 vs. 29.2 days) were not different between the 2 groups. Pain score was significantly higher (median, 4 vs. 3; P=0.005) in women with ovarian endometrioma. Conclusion We found that the menstrual characteristics between women with ovarian endometrioma and women with other benign ovarian tumors were similar. We also observed that low BMI may be one of the risk factor for endometriosis. Keywords: Endometriosis; Menstruation; Menorrhagia; Body mass index Introduction Endometriosis is a common gynecologic condition that affects women throughout their reproductive life. Its prevalence rate is 10% 15% in women of reproductive age and may be as high as 30% in infertile women [1]. Risk factors for endometriosis remain largely unknown; however, it has previously been suggested that young age, low parity, thinness, alcohol usage, cigarette smoking, early age at menarche, and specific menstrual characteristics may be risk-elevating factors for endometriosis [2-7]. Because retrograde flow of menstrual blood cells during menstruation is considered as the dominant theory for the development of endometriosis, a close association between menstrual characteristics and occurrence of endometriosis may be a plausible scenario. Moreover, specific menstrual characteristics, such as short Received: 2017.04.14. Revised: 2017.07.11. Accepted: 2017.07.20. Corresponding author: Byung Chul Jee Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, 82 Gumi-ro 173-beon-gil, Bundanggu, Seongnam 13620, Korea E-mail: blasto@snubh.org http://orcid.org/0000-0003-2289-6090 Articles published in Obstet Gynecol Sci are open-access, distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons. org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Copyright 2018 Korean Society of Obstetrics and Gynecology 142

Ji Yeon Han, et al. Endometriosis and menstruation cycle length and long duration of menstrual flow, have been identified as possible risk factors [8]. The duration of menstrual bleeding has also been reported as a potential independent risk factor for endometriosis in infertile Iranian women [5]. However, several studies have indicated that the duration of menstrual bleeding may be similar between women with and without endometriosis [3,9]. It has been an ongoing debate whether frequent menstrual cycle is a risk factor for endometriosis; however, a recent meta-analysis revealed that menstrual cycle length of less than or equal to 27 days may increase the risk of endometriosis, whereas a cycle length of greater than or equal to 29 days may decrease the risk [6]. With respect to the amount of menstrual bleeding, a significantly higher amount was observed in women with endometriosis compared with women without endometriosis, according to a study from Italy (median score 110 vs. 84 when assessed by pictorial blood loss assessment chart [PBAC]) [9]. In addition, it has also been reported that moderate to severe menstrual bleeding was significantly more prevalent in women with endometriosis compared with those without endometriosis [3,5]. To date, only a few studies have evaluated the association between the amount of menstrual bleeding and presence of endometriosis. Moreover, to the best of our knowledge, there is a limited number of studies that used objective methods to assess the amount of menstrual bleeding, such as PBAC score or alkaline hematin measurement. More importantly, data on the amount of menstrual bleeding in Korean women are not available. Thus, in the present study, we evaluated the menstrual characteristics of Korean women with or without endometriosis. Materials and methods A total of 95 women younger than 39 years of age, who received laparoscopic surgery for having ovarian endometrioma (n=46) or other benign ovarian tumors (n=49) between April 2016 and February 2017, was included for analysis. The Institutional Review Board of Seoul National University Hospital approved our study (IRB No. 1706-045-857). We excluded women with uterine diseases that could potentially affect the menstrual characteristics, such as myoma uteri, endometrial polyps, and adenomyosis. We also excluded women who received gynecologic surgeries within the past 6 months for the aforementioned uterine diseases. Moreover, we also excluded women who had taken anticoagulants or hormonal medications (a gonadotropin-releasing hormone agonist, glucocorticoids, oral contraceptives, progestins, or intrauterine device) within the last 6 months, because it is possible that these drugs may affect the menstrual characteristics. From the electronic medical records at admission, the data regarding age, height, body weight, and preoperative blood hemoglobin level were collected. At admission, menstrual characteristics, such as cycle length, cycle regularity, and menstrual duration, were collected by using a questionnaire. The amount of menstrual bleeding was recorded using a PBAC, and the severity of dysmenorrhea was recorded using a visual analogue scale. After laparoscopic surgery, all patients were divided into 2 groups based on the final histology of the pathologic report: the ovarian endometrioma group (n=46) and the other benign ovarian tumors group (without endometriosis) (n=49). The endometriosis score was evaluated in accordance with the revised guidelines proposed by the American Society for Reproductive Medicine [10]. All statistical analyses were performed using the Statistical Package for Social Sciences software (SPSS version 22.0; SPSS Inc., Chicago, IL, USA). When the numeric data between the 2 groups were compared, nonparametric Wilcoxon test was used, and the data were expressed as the median and 95% confidence interval. When the proportions between the 2 groups were compared, the χ 2 test or the Fisher s exact test was used, when appropriate. A P-value of less than 0.05 was considered statistically significant. Results In the ovarian endometrioma group, 17 women had stage III endometriosis and 29 women had stage IV endometriosis. Among the 49 women with other benign ovarian tumors, the final histology was as follows; 33 mature cystic teratomas, 5 mucinous cystadenomas, 4 follicular cysts, 3 paratubal cysts, 2 serous cystadenomas, 1 hydrosalpinx, and 1 tubo-ovarian abscess. As shown in Table 1, age and parity were similar in both groups. Women with ovarian endometrioma showed a significantly lower body mass index (BMI) and preoperative hemoglobin level. Pain score was significantly higher in women 143

Vol. 61, No. 1, 2018 Table 1. Clinical and menstrual characteristics in women with or without ovarian endometrioma Characteristics Ovarian endometrioma (n=46) Benign ovarian tumors (n=49) Age (yr) 30.5 (29.2 31.8) 29 (27.5 30.4) Married 14 (30.4) 16 (32.7) Parous 10 (22) 11 (22) P-value Body mass index (kg/m 2 ) 20.9 (20.1 21.6) 22.1 (21.3 23.0) 0.031 Preoperative hemoglobin (g/dl) 12.7 (12.4 13.0) 13.3 (12.9 13.7) 0.012 Preoperative hemoglobin <10 g/dl 0 2 (4) Pain score 4 (3.5 4.4) 3 (2.5 3.5) 0.005 Menstrual amount by PBAC 183 (155 211) 165 (133 197) PBAC score 100 33 (72) 35 (71) 130 29 (63) 30 (61) 160 23 (50) 19 (39) Menstrual duration (day) 6 (6 7) 6 (5 6) Menstrual cycle Regular 40 (87) 36 (73) Irregular 6 (13) 14 (27) Cycle length in women with regular cycle (day) 29.0 (28 30) 29.2 (28 30) Values are presented as median (95% confidence interval) or number (%)., not significant; PBAC, pictorial blood loss assessment chart. Table 2. Clinical and menstrual characteristics according to the stage of endometriosis Characteristics Endometriosis III (n=17) Endometriosis IV (n=29) P-value Age (yr) 30.3 (28.2 32.5) 30.6 (28.9 32.3) Married 5 (29) 9 (31) Parous 3 (18) 7 (24) Body mass index (kg/m 2 ) 20.9 (19.5 22.3) 20.8 (19.9 21.7) Preoperative hemoglobin (g/dl) 12.8 (12.3 13.3) 12.6 (12.2 13.0) Pain score 3.8 (3.0 4.6) 4.0 (3.4 4.7) Menstrual amount by PBAC 211 (156 267) 167 (137 197) PBAC score 100 13 (76) 20 (69) 130 11 (65) 18 (62) 160 9 (53) 14 (48.3) Menstrual duration (day) 6.6 (6.0 7.1) 6.1 (5.7 6.5) Menstrual cycle Regular 13 (76) 27 (93.1) Irregular 4 (24) 2 (6.9) Cycle length in women with regular cycle (day) 31.0 (29.4 32.6) 28.6 (27.6 29.5) Values are presented as median (95% confidence interval) or number (%)., not significant; PBAC, pictorial blood loss assessment chart. with ovarian endometrioma. However, cycle regularity, cycle length in women with regular cycle, menstrual duration, and amount of menstrual bleeding were not different between the 2 groups. It is worth noting that we did not analyze the 144

Ji Yeon Han, et al. Endometriosis and menstruation age of menarche because this data was not available in more than half of our participants. According to the analysis comparing the clinical and menstrual characteristics against the stage of endometriosis, we found that age, BMI, pain score, cycle regularity, cycle length in women with regular cycle, menstrual duration, and amount of menstrual bleeding were all similar between women with stage III endometriosis and those with stage IV endometriosis (Table 2). Discussion In the present study, the amount of menstrual bleeding was similar between women with and without endometriosis. Moreover, there was no difference in the cycle length, menstrual duration, or menstrual regularity between the 2 groups. This result is inconsistent with previous reports, which showed that amount of menstrual bleeding is greater (110 vs. 84) or menorrhagia is more prevalent in women with endometriosis compared with women without endometriosis [3,5,9]. Short cycle length has previously been proposed as a risk factor for endometriosis [6,8]. However, it has also been asserted that long duration of menstrual flow may be a risk factor for endometriosis [3,5,9]. To date, whether the amount of menstrual bleeding should be considered as a risk factor for endometriosis remains to be inconclusive, because there has only been one study assessing the amount of menstrual bleeding using the PBAC score [9]. In our study, the median PBAC score was rather high in both groups (183 vs. 165), when compared with the PBAC score (110 vs. 84) from a previous report [9]. The cut-off point of the PBAC score for the diagnosis of menorrhagia has traditionally been 130 [11]. When using 130 as the cut-off point in our study, the prevalence of menorrhagia was 63% in women with endometriosis and 61% in women without endometriosis. However, in a recent study, 160 was proposed and used as the cut-off point for menorrhagia [12]. They reported that the median PBAC values in women who reported their blood flow as minimal, normal, or heavy were 45 (range, 2 204), 116 (range, 13 610), and 255 (range, 13 1,740). When using this new cut-off point in our study, the prevalence of menorrhagia was much higher in women with endometriosis (50% vs. 39%); but it did not reach statistical significance. Because there has not been any study investigating a baseline reference PBAC score for menstrual amount in Korean women, it is unknown whether our study population is representative of women with normal or abnormal menstrual amount. In the present study, the BMI was significantly lower in women with endometriosis. This is consistent with a previous report that concluded thinness as a risk factor for endometriosis [13]. The mechanism behind this remains largely unknown. According to a previous report, thin women generally have low level of circulating leptin [13]. This study also reported that lower concentration of leptin in the peritoneal fluid may be associated with greater severity of endometriosis [13]. Moreover, young age and low parity have also been suggested as risk factors for endometriosis in previous reports [2]; however, in our study, age and parity were not different between the endometriosis group and non-endometriosis group. In our study, the preoperative hemoglobin value was lower in women with endometriosis; however, the clinical significance of this might be minimal since the hemoglobin values, despite being lower, were mostly within normal range. In our study, the pain score was significantly higher in women with endometriosis. This is consistent with the alreadyexisting knowledge of dysmenorrhea causing endometriosis. In general, pain score is not associated with endometriosis stage, and we found a similar pain score between those with stage III endometriosis (median VAS score 3.8) and stage IV endometriosis (median VAS score 4). The PBAC score system has been proposed by Higham et al. [14] as a means to evaluate the amount of menstrual bleeding. They showed that this scoring system is directly correlated with the uterine blood loss measured by the alkaline hematin method, and suggested a cut-off value of 100, at which point, both sensitivity and specificity for menorrhagia was shown to be greater than 80%, according to their validation study [14]. However, in a subsequent study, the cut-off value for menorrhagia has been suggested to be 130; with this score, the sensitivity was 91% and the specificity was 81.9% [11]. In a recent study, the cut-off value for menorrhagia has been proposed to be 160; with this score, the sensitivity was 78.5% and the specificity was 75.8% [12]. Taken together, we can conclude that the criteria for the PBAC score system as a means to diagnosis menorrhagia may increase over time. Although the reason behind is unclear, it is likely due to the increasing prevalence of uterine diseases affecting the menstrual amount. 145

Vol. 61, No. 1, 2018 The advantage of our study is that we excluded women with past or current uterine diseases as well as those who had taken anticoagulants or hormonal medications within the past 6 months. It is worth noting that these could affect menstrual characteristics. Another advantage is that we included surgically confirmed control group, in whom endometriosis was absent. In our study, we selected only those who were 39 years or younger, since women older than 40 years would have a high possibility of menorrhagia due to uterine diseases, such as adenomyosis or myoma uteri. One limitation of this study is that we were unable to investigate whether alcohol usage and cigarette smoking were risk factors for endometriosis. In addition, age of menarche was not incorporated in the final analysis due to lack of available data. Although age of menarche was included in the questionnaire, less than half of the participants responded; it is likely that most women do not remember their age of menarche. In conclusion, we found similar menstrual characteristics (except pain score) between women with endometriosis and women without endometriosis. Low BMI appears to be one of the risk factor for endometriosis. More research with a large population is necessary to clarify the association between menstrual characteristics and endometriosis risk. In addition, a baseline reference PBAC score for menstrual amounts in Korean women should be investigated. Conflict of Interest No potential conflict of interest relevant to this article was reported. References 1. Witz CA, Burns WN. Endometriosis and infertility: is there a cause and effect relationship? Gynecol Obstet Invest 2002;53 Suppl 1:2-11. 2. Missmer SA, Hankinson SE, Spiegelman D, Barbieri RL, Marshall LM, Hunter DJ. Incidence of laparoscopically confirmed endometriosis by demographic, anthropometric, and lifestyle factors. Am J Epidemiol 2004;160:784-96. 3. Calhaz-Jorge C, Mol BW, Nunes J, Costa AP. Clinical predictive factors for endometriosis in a Portuguese infertile population. Hum Reprod 2004;19:2126-31. 4. Parazzini F, Cipriani S, Bravi F, Pelucchi C, Chiaffarino F, Ricci E, et al. A metaanalysis on alcohol consumption and risk of endometriosis. Am J Obstet Gynecol 2013;209:106.e1-10. 5. Moini A, Malekzadeh F, Amirchaghmaghi E, Kashfi F, Akhoond MR, Saei M, et al. Risk factors associated with endometriosis among infertile Iranian women. Arch Med Sci 2013;9:506-14. 6. Wei M, Cheng Y, Bu H, Zhao Y, Zhao W. Length of menstrual cycle and risk of endometriosis: a meta-analysis of 11 casecontrol studies. Medicine (Baltimore) 2016;95:e2922. 7. Shahbazi S, Shahrabi-Farahani M. Evaluation of the correlation between body mass index and endometriosis among Iranian fertile women. Gynecol Endocrinol 2016;32:157-60. 8. Eskenazi B, Warner ML. Epidemiology of endometriosis. Obstet Gynecol Clin North Am 1997;24:235-58. 9. Vercellini P, De Giorgi O, Aimi G, Panazza S, Uglietti A, Crosignani PG. Menstrual characteristics in women with and without endometriosis. Obstet Gynecol 1997;90:264-8. 10. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril 1997;67:817-21. 11. Janssen CA, Scholten PC, Heintz AP. A simple visual assessment technique to discriminate between menorrhagia and normal menstrual blood loss. Obstet Gynecol 1995;85:977-82. 12. Hald K, Lieng M. Assessment of periodic blood loss: interindividual and intraindividual variations of pictorial blood loss assessment chart registrations. J Minim Invasive Gynecol 2014;21:662-8. 13. Mahutte NG, Matalliotakis IM, Goumenou AG, Vassiliadis S, Koumantakis GE, Arici A. Inverse correlation between peritoneal fluid leptin concentrations and the extent of endometriosis. Hum Reprod 2003;18:1205-9. 14. Higham JM, O'Brien PM, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol 1990;97:734-9. 146